Xiaojiong Jia

857 total citations
26 papers, 531 citations indexed

About

Xiaojiong Jia is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases. According to data from OpenAlex, Xiaojiong Jia has authored 26 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Medicine, 10 papers in Pharmacology and 5 papers in Infectious Diseases. Recurrent topics in Xiaojiong Jia's work include Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antibiotic Use and Resistance (5 papers). Xiaojiong Jia is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Antibiotic Use and Resistance (5 papers). Xiaojiong Jia collaborates with scholars based in China, United States and Hong Kong. Xiaojiong Jia's co-authors include Hua Zou, Liping Zhang, Xiuyu Xu, Shuangshuang Yang, Si Cheng, Hang Liu, Shan Sun, Ju Cao, Shifeng Huang and Liping Zhang and has published in prestigious journals such as Frontiers in Microbiology, BMC Bioinformatics and Cancer Letters.

In The Last Decade

Xiaojiong Jia

25 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojiong Jia China 16 253 121 118 93 89 26 531
Mingzhe Ning China 11 204 0.8× 62 0.5× 140 1.2× 28 0.3× 61 0.7× 22 391
О Н Ершова Russia 12 249 1.0× 89 0.7× 105 0.9× 42 0.5× 33 0.4× 39 468
Michael Dudley United States 15 223 0.9× 76 0.6× 85 0.7× 163 1.8× 92 1.0× 26 431
Xixi Shen China 13 61 0.2× 91 0.8× 159 1.3× 24 0.3× 80 0.9× 51 524
Dong Hoon Shin South Korea 11 102 0.4× 137 1.1× 136 1.2× 25 0.3× 49 0.6× 22 438
Hoda Hassan Egypt 9 106 0.4× 88 0.7× 214 1.8× 24 0.3× 25 0.3× 18 437
Andrew Chou United States 9 91 0.4× 51 0.4× 160 1.4× 27 0.3× 59 0.7× 20 370
Fumihiro Yoshimura Japan 9 198 0.8× 39 0.3× 112 0.9× 101 1.1× 39 0.4× 38 603
Muhammad Yasir United Kingdom 12 94 0.4× 46 0.4× 131 1.1× 27 0.3× 65 0.7× 50 473
Mi-Ran Seo South Korea 11 59 0.2× 167 1.4× 123 1.0× 28 0.3× 119 1.3× 23 355

Countries citing papers authored by Xiaojiong Jia

Since Specialization
Citations

This map shows the geographic impact of Xiaojiong Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojiong Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojiong Jia more than expected).

Fields of papers citing papers by Xiaojiong Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojiong Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojiong Jia. The network helps show where Xiaojiong Jia may publish in the future.

Co-authorship network of co-authors of Xiaojiong Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojiong Jia. A scholar is included among the top collaborators of Xiaojiong Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojiong Jia. Xiaojiong Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yongqi, et al.. (2024). Epidemiology of cryptococcal meningitis and fluconazole heteroresistance in Cryptococcus neoformans isolates from a teaching hospital in southwestern China. Microbiology Spectrum. 12(8). e0072524–e0072524. 1 indexed citations
3.
Wen, Xiaoxia, Jiasi Wang, Xiaojiong Jia, et al.. (2022). Clinlabomics: leveraging clinical laboratory data by data mining strategies. BMC Bioinformatics. 23(1). 387–387. 31 indexed citations
4.
Yan, Zhengjian, Lei Chu, Xiaojiong Jia, Lin Lü, & Si Cheng. (2021). Myelin basic protein enhances axonal regeneration from neural progenitor cells. Cell & Bioscience. 11(1). 80–80. 19 indexed citations
5.
Zou, Hua, Xiaojiong Jia, He Xiao, et al.. (2021). Emerging Threat of Multidrug Resistant Pathogens From Neonatal Sepsis. Frontiers in Cellular and Infection Microbiology. 11. 694093–694093. 24 indexed citations
7.
Jia, Xiaojiong, Si Cheng, Hua Zou, et al.. (2021). Elevated Red Blood Cell Distribution Width as a Poor Prognostic Factor in Patients With Hematopoietic Stem Cell Transplantation. Frontiers in Oncology. 10. 565265–565265. 2 indexed citations
8.
Lin, Qiuxia, et al.. (2021). Clinical and Microbiological Characterization of Carbapenem-Resistant Enterobacteriales: A Prospective Cohort Study. Frontiers in Pharmacology. 12. 716324–716324. 10 indexed citations
10.
Jia, Xiaojiong, et al.. (2020). Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia. International Journal of Antimicrobial Agents. 55(3). 105832–105832. 17 indexed citations
11.
Ren, Fang, Vincent Kam Wai Wong, Hongyan Xu, et al.. (2019). Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production. EBioMedicine. 49. 232–246. 16 indexed citations
12.
Liu, Hang, Xiaojiong Jia, Hua Zou, et al.. (2019). Detection and characterization of tigecycline heteroresistance in E. cloacae : clinical and microbiological findings. Emerging Microbes & Infections. 8(1). 564–574. 28 indexed citations
13.
Jia, Xiaojiong, et al.. (2019). <p>Risk factors with the development of infection with tigecycline- and carbapenem-resistant <em>Enterobacter cloacae</em></p>. Infection and Drug Resistance. Volume 12. 667–674. 6 indexed citations
14.
Yang, Qiuxia, Shan Zhong, Lin He, et al.. (2019). PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway. Cancer Letters. 452. 90–102. 64 indexed citations
16.
Jia, Xiaojiong, Wei Dai, Shuangshuang Yang, et al.. (2018). Carbapenem-Resistant E. cloacae in Southwest China: Molecular Analysis of Resistance and Risk Factors for Infections Caused by NDM-1-Producers. Frontiers in Microbiology. 9. 2694–2694. 26 indexed citations
17.
Jia, Xiaojiong, et al.. (2018). Carbapenem-resistant and cephalosporin-susceptible <em>Pseudomonas aeruginosa</em>: a notable phenotype in patients with bacteremia. Infection and Drug Resistance. Volume 11. 1225–1235. 26 indexed citations
18.
Cao, Ju, et al.. (2017). Up-regulation of chemokine CXCL13 in systemic candidiasis. Clinical Immunology. 191. 1–9. 6 indexed citations
19.
Jia, Xiaojiong, et al.. (2017). Heteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections. International Journal of Antimicrobial Agents. 51(3). 413–421. 39 indexed citations
20.
Jia, Xiaojiong, et al.. (2015). Retrospective analysis of hospital-acquired linezolid-nonsusceptible enterococci infection in Chongqing, China, 2011-2014. American Journal of Infection Control. 43(12). e101–e106. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026